How Portage Biotech Created A Lean, New Drug Development Model

By Ed Miseta, Chief Editor, Clinical Leader

Dr. Ian Walters was noticing a disturbing trend in the industry. After nearly two decades of working in pharma, seven years of which at Bristol Myers Squibb (BMS), he became aware that Big Pharma companies would often lament that small biotechs did not develop drugs the same way as their larger counterparts. Those differences would often lead many large pharma companies to question whether they should take a risk on a small biotech instead of just doubling down on their own efforts.